Results 171 to 180 of about 162,094 (212)
Therapy-related acute non-lymphoid leukemia.
Haematologica, 1987 G. Papa +2 more
openaire +2 more sources
Systemic CD3+ T-Cell Lymphoblastic Leukemia in a Bearded Dragon (<i>Pogona vitticeps)</i>: Clinical, Therapeutic, and Pathological Findings. [PDF]
Animals (Basel)Miljković J +10 more
europepmc +1 more source
Lymphoid leukemia myelogram study.
Boletin medico del Hospital Infantil de Mexico, 2010 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acute lymphoid leukemia etiopathogenesis
Molecular Biology Reports, 2021Acute lymphoid leukemia (ALL) is a type of hematological neoplasm that affects the precursor cells of strains B, T and NK, with a higher incidence in the pediatric range. The pathophysiology of ALL is characterized by chromosomal abnormalities and genetic alterations involved in the differentiation and proliferation of lymphoid precursor cells ...
Thiago Cezar Fujita +3 more
openaire +2 more sources
Pediatric Annals, 1983
Acute non-lymphoid leukemia is a group of hematologic neoplasms which have been the subject of intensive basic and clinical research. These studies have led to a better understanding of the genetic basis of leukemia and may ultimately help establish the molecular mechanisms of malignant transformation.
C, Dampier, R R, Chilcote
openaire +2 more sources
Acute non-lymphoid leukemia is a group of hematologic neoplasms which have been the subject of intensive basic and clinical research. These studies have led to a better understanding of the genetic basis of leukemia and may ultimately help establish the molecular mechanisms of malignant transformation.
C, Dampier, R R, Chilcote
openaire +2 more sources
Pediatric Annals, 1983
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire +2 more sources
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire +2 more sources
Hématologie, 2013
hma.2013.0854 Auteur(s) : Bruno Cazin b-cazin@chru-lille.fr Service des maladies du sang, CHRU de Lille, Hopital Huriez, Lille Comment traiter une leucemie lymphoide chronique (LLC) ? Avant de repondre a cette question, se pose une question prealable : dois-je traiter ce patient atteint de LLC ?
openaire +1 more source
hma.2013.0854 Auteur(s) : Bruno Cazin b-cazin@chru-lille.fr Service des maladies du sang, CHRU de Lille, Hopital Huriez, Lille Comment traiter une leucemie lymphoide chronique (LLC) ? Avant de repondre a cette question, se pose une question prealable : dois-je traiter ce patient atteint de LLC ?
openaire +1 more source
Immunophenotyping of Chronic Lymphoid Leukemias
Journal of Clinical Oncology, 2008The 1983 article entitled “Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations,” which is reprinted in this issue of the Journal of Clinical Oncology, was one of the first reporting the use of monoclonal antibodies to expand the phenotypic characterization of chronic lymphoid ...
openaire +2 more sources